Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02118922 · ClinicalTrials.gov registry record
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
A clinical trial of Keratoconus and Fuchs Endothelial Dystrophy, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 168
- Enrollment target
- 1
- Study location
NCT02118922 is a study of Keratoconus and Fuchs Endothelial Dystrophy that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 168 participants, below the 1,172-participant average among 21 other Keratoconus trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02118922, a study of Keratoconus and Fuchs Endothelial Dystrophy, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 168 participants
- Enrollment target
- 1
- Study location
Study Summary
We have developed novel Brillouin microscopy and we are testing its potential for keratoconus and ectasia diagnostics. We plan to perform axial scans of the cornea in human volunteers in order to compare biomechanical properties of Keratoconus vs. Normal corneas and compare biomechanical properties of post-LASIK ectasia vs. normal corneas.
Conditions Studied
Interventions
- PROCEDURE Brillouin imaging
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2013-06 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02118922
The ClinicalTrials.gov registry entry for NCT02118922 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,172-participant average among 21 other Keratoconus trials with a reported enrollment target (86% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Keratoconus appearing as the primary indexed condition, and to 1 intervention - of which Brillouin imaging is the first listed.
NCT02118922 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02118922 about?
NCT02118922 is a clinical study titled "A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia". We have developed novel Brillouin microscopy and we are testing its potential for keratoconus and ectasia diagnostics. We plan to perform axial scans of the cornea in human volunteers in order to compare biomechanical properties of Keratoconus vs. Normal corneas and compare biomechanical properties ...
What is the current status of trial NCT02118922?
This trial is currently recruiting. The enrollment target is 168 participants. The study started on 2013-06. Estimated completion is 2026-09.
What conditions does trial NCT02118922 study?
This clinical trial studies the following conditions: Keratoconus, Fuchs Endothelial Dystrophy, Ectasia, Crosslinking.
What interventions are being tested in trial NCT02118922?
The interventions under investigation include: Brillouin imaging (PROCEDURE).
Who is sponsoring clinical trial NCT02118922?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02118922 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
OCT in Diagnosis of Irregular Corneas
RECRUITING
-
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
RECRUITING · Phase 3
-
Collagen Cross-linking in Keratoconus
RECRUITING · NA
-
Corneal Elastography and Patient Specific Modeling
RECRUITING
-
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
RECRUITING · Phase 3
-
Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.